322

  • Internet ҳавола
  • DOI
  • UzSCI тизимида яратилган сана 29-04-2020
  • Ўқишлар сони 278
  • Нашр санаси 07-10-2019
  • Мақола тилиRus
  • Саҳифалар сони121-126
Калит сўзлар
№ Муаллифнинг исми Лавозими Ташкилот номи
1 Djoldasova Y.A.
2 Musabayev E.I.
3 Egamova I.N.
4 Xodjayeva M.E.
5 Ibadullayeva N.S.
№ Ҳавола номи
1 1. Bensong Duan., Jiangfeng Hu., Tongyangzi Zhang., Xu Luo. et. al. MiRNA-338-3p/CDK4 signaling pathway suppressed hepatic stellate cell activation and proliferation // BMC Gastroenterology. – 2017. - 17:12. - Р.1-9. 2. Bo-Xun Jin., Yong-Hong Zhang., Wen-Jing Jin., Xiang-Ying Sun. et. al. MicroRNA panels as disease biomarkers distinguishing hepatitis B virus infection caused hepatitis and liver cirrhosis // Scientific Reports. - 5:15026. - P.1-12. - DOI:10.1038/srep15026. 3. Cheng H.R., Kao J.H., Wu H.L., Tseng T.C. et. al. Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection // Hepatol Int. – 2015. – Jan 9(1). – P.35-42. 4. Eman El-Ahwany., Faten Nagy., Mona Zoheiry., Mohamed Shemis. et. al. Circulating miRNAs as Predictor Markers for Activation of Hepatic Stellate Cells and Progression of HCV-Induced Liver Fibrosis // Electronic Physician January 2016. - Volume 8. - Issue: 1. - P.1804-1810. 5. Gang Li., Guohong Cai., Demin Li., Wen Yin. MicroRNAs and liver disease: viral hepatitis, liver fibrosis and hepatocellular carcinoma // Postgrad Med J. -2014. – 90. – P.106–112. 6. Jennifer Louten., Michael Beach., Kristina Palermino., Maria Weeks., Gabrielle Holenstein. MicroRNAs Expressed during Viral Infection: Biomarker Potential and Therapeutic Considerations // Biomarker Insights.– 2015. -10(S4).- P.25-52. 7. Joeri Lambrecht., Inge Mannaerts., Leo A. van Grunsven. The role of miRNAs in stress-responsive hepatic stellate cells during liver fibrosis // Frontiers in Physiology. – 2015. –July. - Volume 6. - Article 209. - Р1-12. - www.frontiersin.org. 8. Joeri Lambrecht, Pieter Jan Poortmans., Stefaan Verhulst., Hendrik Reynaert. et. al. Circulating ECV-Associated miRNAs as Potential Clinical Biomarkers in Early Stage HBV and HCV Induced Liver Fibrosis // Frontiers in Pharmacology. – 2017. – February. - Volume 8. - Article 56. - Р.1-13. - www.frontiersin.org. 9. Jun Hu., Yaxing Xu., Junli Hao., Saifeng Wang. et. al. MiR-122 in hepatic function and liver diseases // Protein Cell. – 2012. - 3(5). – P.364–371. 10. Kyoungsub Song., Chang Han., Srikanta Dash., Luis A Balart., Tong Wu. MiR-122 in hepatitis B virus and hepatitis C virus dual infection // World J Hepatol. – 2015. - March 27. - 7(3). - P.498-506. 11. Livak K.J., Thomas D Schmittgen. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2^-ΔΔCt Method // METHODS 25, 2001, 402-408 doi:10.1006/meth.2001.1262, available online at http://www.idealibrary.com. 12. Matsuura K., De Giorgi V., Schechterly C., Wang R.Y. et. al. Circulating let-7 levels in plasma and extracellular vesicles correlate with hepatic fibrosis progression in chronic hepatitis C // Hepatology. – 2016. – Sep. 64(3). - P.732-745. 13. Omran A.A., Osman K.S., Kamel H.M., Abdel-Naem E.A., Hasan D.E. MicroRNA-122 as a Novel Non-Invasive Marker of Liver Fibrosis in Hepatitis C Virus Patients // Clin Lab. – 2016. - Jul 1. - 62(7). - P.1329-1337. 14. Trebicka J., Anadol E., Elfimova N., Strack I., Roggendorf M. et. al. Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis // J Hepatol. - 2013. – Feb. 58(2). – P.234-239. 15. Tünde Halász., Gábor Horváth., Gabriella Pár., Klára Werling. et. al. MiR-122 negatively correlates with liver fibrosis as detected by histology and FibroScan // World J Gastroenterol. – 2015. - July 7. 21(25). - P.7814-7823.
Кутилмоқда